Source:http://linkedlifedata.com/resource/pubmed/id/20812013
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-10-22
|
pubmed:abstractText |
Stimulation of the TNF receptors CD30 and CD95 exerts opposite effects. Crosstalk of both receptors is unknown. We aimed to reveal regulatory mechanisms of CD30-induced effects on CD95 signaling of cALCL cell lines. "CD30/CD95 crosstalk analysis" was performed in cALCL cell lines by comparison of CD30 or CD95 stimulation and CD30/CD95 costimulation. Receptor expression and induction of apoptosis was investigated by flow cytometry. mRNA expression of CD30-inducible genes (cFLIP, TRAF1, cIAP2, and A20) was compared by semiquantitative reverse transcription (RT-RQ-) PCR in stimulated and unstimulated cells. Protein expression of I?B?, p100/p52, caspase-8, caspase-3, and cFLIP was analyzed by immunoblotting. A lentiviral-based shRNA-mediated approach was used to inhibit cFLIP expression. CD30/CD95 crosstalk experiments revealed that CD30 ligation leads to NF?B-mediated cFLIP upregulation in cALCL cells, which in turn enhanced resistance to CD95-mediated apoptosis. This effect is based on the CD30-induced upregulation of cFLIP. Knockdown of cFLIP restores sensitivity to CD95-mediated apoptosis. We conclude that the anti-apoptotic function of CD30 antibodies should be kept in mind if CD30 antibody-based therapeutic concepts for ALCL lymphoma are considered.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD30,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/CASP8 and FADD-Like Apoptosis...,
http://linkedlifedata.com/resource/pubmed/chemical/CFLAR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/FAS protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1432-1963
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
31 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
193-8
|
pubmed:meshHeading |
pubmed-meshheading:20812013-Antigens, CD30,
pubmed-meshheading:20812013-Antigens, CD95,
pubmed-meshheading:20812013-Apoptosis,
pubmed-meshheading:20812013-CASP8 and FADD-Like Apoptosis Regulating Protein,
pubmed-meshheading:20812013-Cell Line, Tumor,
pubmed-meshheading:20812013-Flow Cytometry,
pubmed-meshheading:20812013-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20812013-Humans,
pubmed-meshheading:20812013-Lymphoma, Large-Cell, Anaplastic,
pubmed-meshheading:20812013-Lymphoma, T-Cell, Cutaneous,
pubmed-meshheading:20812013-RNA, Messenger,
pubmed-meshheading:20812013-Receptor Cross-Talk,
pubmed-meshheading:20812013-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20812013-Skin,
pubmed-meshheading:20812013-Skin Neoplasms,
pubmed-meshheading:20812013-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
[cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].
|
pubmed:affiliation |
Institut für Pathologie, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin. burkhard.hirsch@charite.de
|
pubmed:publicationType |
Journal Article,
English Abstract
|